nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—CYP3A7—Ifosfamide—germ cell cancer	0.12	0.171	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Ifosfamide—germ cell cancer	0.12	0.171	CbGbCtD
Zalcitabine—SLC22A7—Methotrexate—germ cell cancer	0.0973	0.139	CbGbCtD
Zalcitabine—CYP3A5—Ifosfamide—germ cell cancer	0.0897	0.128	CbGbCtD
Zalcitabine—CYP2C9—Ifosfamide—germ cell cancer	0.0602	0.086	CbGbCtD
Zalcitabine—CYP3A5—Etoposide—germ cell cancer	0.0429	0.0613	CbGbCtD
Zalcitabine—SLC22A6—Methotrexate—germ cell cancer	0.0414	0.0592	CbGbCtD
Zalcitabine—CYP3A4—Ifosfamide—germ cell cancer	0.035	0.05	CbGbCtD
Zalcitabine—CYP2C9—Cisplatin—germ cell cancer	0.0293	0.0418	CbGbCtD
Zalcitabine—CYP2D6—Vinblastine—germ cell cancer	0.0292	0.0417	CbGbCtD
Zalcitabine—CYP3A4—Vinblastine—germ cell cancer	0.0186	0.0265	CbGbCtD
Zalcitabine—CYP3A4—Etoposide—germ cell cancer	0.0167	0.0239	CbGbCtD
Zalcitabine—CYP2C9—cardial valve—germ cell cancer	0.0103	0.154	CbGeAlD
Zalcitabine—Lamivudine—SLC22A3—germ cell cancer	0.00447	1	CrCbGaD
Zalcitabine—CYP3A43—endocrine gland—germ cell cancer	0.00236	0.0355	CbGeAlD
Zalcitabine—CYP3A43—testis—germ cell cancer	0.00225	0.0338	CbGeAlD
Zalcitabine—CYP2C9—urine—germ cell cancer	0.00222	0.0333	CbGeAlD
Zalcitabine—SLC29A2—adrenal gland—germ cell cancer	0.00175	0.0264	CbGeAlD
Zalcitabine—CYP3A4—urine—germ cell cancer	0.00169	0.0254	CbGeAlD
Zalcitabine—CYP2D6—urine—germ cell cancer	0.00166	0.025	CbGeAlD
Zalcitabine—SLC29A1—trigeminal ganglion—germ cell cancer	0.00152	0.0229	CbGeAlD
Zalcitabine—SLC29A2—endocrine gland—germ cell cancer	0.00152	0.0229	CbGeAlD
Zalcitabine—DCK—trigeminal ganglion—germ cell cancer	0.00145	0.0218	CbGeAlD
Zalcitabine—DCK—embryo—germ cell cancer	0.0014	0.0211	CbGeAlD
Zalcitabine—SLC29A2—cerebellum—germ cell cancer	0.00134	0.0201	CbGeAlD
Zalcitabine—DCK—retina—germ cell cancer	0.00124	0.0187	CbGeAlD
Zalcitabine—SLC29A1—telencephalon—germ cell cancer	0.0012	0.018	CbGeAlD
Zalcitabine—DCK—telencephalon—germ cell cancer	0.00114	0.0172	CbGeAlD
Zalcitabine—SLC29A1—decidua—germ cell cancer	0.00113	0.017	CbGeAlD
Zalcitabine—SLC29A2—brain—germ cell cancer	0.00109	0.0163	CbGeAlD
Zalcitabine—DCK—decidua—germ cell cancer	0.00108	0.0163	CbGeAlD
Zalcitabine—CYP3A7—endocrine gland—germ cell cancer	0.00106	0.0159	CbGeAlD
Zalcitabine—SLC29A2—lymph node—germ cell cancer	0.00105	0.0158	CbGeAlD
Zalcitabine—SLC29A1—gonad—germ cell cancer	0.000998	0.015	CbGeAlD
Zalcitabine—SLC29A1—uterus—germ cell cancer	0.000992	0.0149	CbGeAlD
Zalcitabine—SLC22A7—endocrine gland—germ cell cancer	0.000978	0.0147	CbGeAlD
Zalcitabine—SLC29A1—pituitary gland—germ cell cancer	0.000974	0.0146	CbGeAlD
Zalcitabine—DCK—gonad—germ cell cancer	0.000954	0.0143	CbGeAlD
Zalcitabine—DCK—uterus—germ cell cancer	0.000947	0.0142	CbGeAlD
Zalcitabine—SLC22A7—testis—germ cell cancer	0.000932	0.014	CbGeAlD
Zalcitabine—DCK—pituitary gland—germ cell cancer	0.00093	0.014	CbGeAlD
Zalcitabine—DCK—medulla oblongata—germ cell cancer	0.000898	0.0135	CbGeAlD
Zalcitabine—SLC29A1—adrenal gland—germ cell cancer	0.00087	0.0131	CbGeAlD
Zalcitabine—SLC29A1—bone marrow—germ cell cancer	0.000842	0.0126	CbGeAlD
Zalcitabine—DCK—adrenal gland—germ cell cancer	0.000831	0.0125	CbGeAlD
Zalcitabine—DCK—midbrain—germ cell cancer	0.000821	0.0123	CbGeAlD
Zalcitabine—SLC29A1—female gonad—germ cell cancer	0.000811	0.0122	CbGeAlD
Zalcitabine—DCK—bone marrow—germ cell cancer	0.000804	0.0121	CbGeAlD
Zalcitabine—DCK—spinal cord—germ cell cancer	0.000801	0.012	CbGeAlD
Zalcitabine—DCK—female gonad—germ cell cancer	0.000775	0.0116	CbGeAlD
Zalcitabine—SLC29A1—endocrine gland—germ cell cancer	0.000754	0.0113	CbGeAlD
Zalcitabine—SLC29A1—head—germ cell cancer	0.000745	0.0112	CbGeAlD
Zalcitabine—DCK—endocrine gland—germ cell cancer	0.000721	0.0108	CbGeAlD
Zalcitabine—SLC29A1—testis—germ cell cancer	0.00072	0.0108	CbGeAlD
Zalcitabine—DCK—head—germ cell cancer	0.000712	0.0107	CbGeAlD
Zalcitabine—SLC22A7—brain—germ cell cancer	0.000699	0.0105	CbGeAlD
Zalcitabine—DCK—testis—germ cell cancer	0.000687	0.0103	CbGeAlD
Zalcitabine—SLC22A6—brain—germ cell cancer	0.000675	0.0101	CbGeAlD
Zalcitabine—SLC29A1—cerebellum—germ cell cancer	0.000665	0.00998	CbGeAlD
Zalcitabine—DCK—cerebellum—germ cell cancer	0.000635	0.00953	CbGeAlD
Zalcitabine—SLC29A1—brain—germ cell cancer	0.00054	0.00811	CbGeAlD
Zalcitabine—SLC29A1—lymph node—germ cell cancer	0.000522	0.00783	CbGeAlD
Zalcitabine—DCK—brain—germ cell cancer	0.000516	0.00774	CbGeAlD
Zalcitabine—SLC22A7—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.000511	0.125	CbGpPWpGaD
Zalcitabine—DCK—lymph node—germ cell cancer	0.000498	0.00748	CbGeAlD
Zalcitabine—CYP2D6—brainstem—germ cell cancer	0.000492	0.00739	CbGeAlD
Zalcitabine—Malaise—Bleomycin—germ cell cancer	0.000462	0.00205	CcSEcCtD
Zalcitabine—Leukopenia—Bleomycin—germ cell cancer	0.000459	0.00204	CcSEcCtD
Zalcitabine—Depressed level of consciousness—Methotrexate—germ cell cancer	0.000458	0.00203	CcSEcCtD
Zalcitabine—Skin exfoliation—Methotrexate—germ cell cancer	0.000453	0.00201	CcSEcCtD
Zalcitabine—Chills—Ifosfamide—germ cell cancer	0.000452	0.002	CcSEcCtD
Zalcitabine—Arrhythmia—Ifosfamide—germ cell cancer	0.00045	0.00199	CcSEcCtD
Zalcitabine—Vaginal infection—Methotrexate—germ cell cancer	0.000448	0.00199	CcSEcCtD
Zalcitabine—Cough—Bleomycin—germ cell cancer	0.000447	0.00198	CcSEcCtD
Zalcitabine—Alopecia—Ifosfamide—germ cell cancer	0.000445	0.00197	CcSEcCtD
Zalcitabine—Ill-defined disorder—Dactinomycin—germ cell cancer	0.000444	0.00197	CcSEcCtD
Zalcitabine—Anaemia—Dactinomycin—germ cell cancer	0.000442	0.00196	CcSEcCtD
Zalcitabine—CYP2D6—telencephalon—germ cell cancer	0.000437	0.00656	CbGeAlD
Zalcitabine—Myalgia—Bleomycin—germ cell cancer	0.000436	0.00194	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Etoposide—germ cell cancer	0.000434	0.00193	CcSEcCtD
Zalcitabine—Jaundice—Etoposide—germ cell cancer	0.000432	0.00191	CcSEcCtD
Zalcitabine—Discomfort—Bleomycin—germ cell cancer	0.000431	0.00191	CcSEcCtD
Zalcitabine—Malaise—Dactinomycin—germ cell cancer	0.000431	0.00191	CcSEcCtD
Zalcitabine—Decreased appetite—Vinblastine—germ cell cancer	0.000431	0.00191	CcSEcCtD
Zalcitabine—Urine output increased—Methotrexate—germ cell cancer	0.000429	0.0019	CcSEcCtD
Zalcitabine—Bladder pain—Methotrexate—germ cell cancer	0.000429	0.0019	CcSEcCtD
Zalcitabine—Leukopenia—Dactinomycin—germ cell cancer	0.000428	0.0019	CcSEcCtD
Zalcitabine—Pain—Vinblastine—germ cell cancer	0.000424	0.00188	CcSEcCtD
Zalcitabine—Confusional state—Bleomycin—germ cell cancer	0.000422	0.00187	CcSEcCtD
Zalcitabine—Oedema—Bleomycin—germ cell cancer	0.000418	0.00186	CcSEcCtD
Zalcitabine—Visual impairment—Cisplatin—germ cell cancer	0.000418	0.00185	CcSEcCtD
Zalcitabine—Infection—Bleomycin—germ cell cancer	0.000416	0.00184	CcSEcCtD
Zalcitabine—Vision blurred—Ifosfamide—germ cell cancer	0.000413	0.00183	CcSEcCtD
Zalcitabine—Thrombocytopenia—Bleomycin—germ cell cancer	0.00041	0.00182	CcSEcCtD
Zalcitabine—Feeling abnormal—Vinblastine—germ cell cancer	0.000408	0.00181	CcSEcCtD
Zalcitabine—Myalgia—Dactinomycin—germ cell cancer	0.000407	0.00181	CcSEcCtD
Zalcitabine—Ill-defined disorder—Ifosfamide—germ cell cancer	0.000407	0.0018	CcSEcCtD
Zalcitabine—Eye disorder—Cisplatin—germ cell cancer	0.000405	0.0018	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000405	0.0018	CcSEcCtD
Zalcitabine—Anaemia—Ifosfamide—germ cell cancer	0.000405	0.0018	CcSEcCtD
Zalcitabine—Tinnitus—Cisplatin—germ cell cancer	0.000405	0.00179	CcSEcCtD
Zalcitabine—Lymphadenopathy—Methotrexate—germ cell cancer	0.000403	0.00179	CcSEcCtD
Zalcitabine—Flushing—Cisplatin—germ cell cancer	0.000403	0.00179	CcSEcCtD
Zalcitabine—Agitation—Ifosfamide—germ cell cancer	0.000403	0.00179	CcSEcCtD
Zalcitabine—Discomfort—Dactinomycin—germ cell cancer	0.000402	0.00178	CcSEcCtD
Zalcitabine—CYP3A5—female gonad—germ cell cancer	0.000401	0.00603	CbGeAlD
Zalcitabine—Anorexia—Bleomycin—germ cell cancer	0.000399	0.00177	CcSEcCtD
Zalcitabine—Diabetes mellitus—Methotrexate—germ cell cancer	0.000396	0.00176	CcSEcCtD
Zalcitabine—Malaise—Ifosfamide—germ cell cancer	0.000395	0.00175	CcSEcCtD
Zalcitabine—Vertigo—Ifosfamide—germ cell cancer	0.000394	0.00175	CcSEcCtD
Zalcitabine—Leukopenia—Ifosfamide—germ cell cancer	0.000392	0.00174	CcSEcCtD
Zalcitabine—Polyuria—Methotrexate—germ cell cancer	0.000392	0.00174	CcSEcCtD
Zalcitabine—Abdominal pain—Vinblastine—germ cell cancer	0.000392	0.00174	CcSEcCtD
Zalcitabine—Oedema—Dactinomycin—germ cell cancer	0.00039	0.00173	CcSEcCtD
Zalcitabine—Infection—Dactinomycin—germ cell cancer	0.000388	0.00172	CcSEcCtD
Zalcitabine—Arrhythmia—Cisplatin—germ cell cancer	0.000388	0.00172	CcSEcCtD
Zalcitabine—Palpitations—Ifosfamide—germ cell cancer	0.000387	0.00172	CcSEcCtD
Zalcitabine—Alopecia—Cisplatin—germ cell cancer	0.000383	0.0017	CcSEcCtD
Zalcitabine—Cough—Ifosfamide—germ cell cancer	0.000382	0.0017	CcSEcCtD
Zalcitabine—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000382	0.00169	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000381	0.00169	CcSEcCtD
Zalcitabine—Convulsion—Ifosfamide—germ cell cancer	0.00038	0.00168	CcSEcCtD
Zalcitabine—Hypertension—Ifosfamide—germ cell cancer	0.000378	0.00168	CcSEcCtD
Zalcitabine—CYP3A5—endocrine gland—germ cell cancer	0.000373	0.00561	CbGeAlD
Zalcitabine—Dyspnoea—Bleomycin—germ cell cancer	0.000373	0.00165	CcSEcCtD
Zalcitabine—Myalgia—Ifosfamide—germ cell cancer	0.000373	0.00165	CcSEcCtD
Zalcitabine—Arthralgia—Ifosfamide—germ cell cancer	0.000373	0.00165	CcSEcCtD
Zalcitabine—Renal failure acute—Methotrexate—germ cell cancer	0.000373	0.00165	CcSEcCtD
Zalcitabine—Flatulence—Cisplatin—germ cell cancer	0.000372	0.00165	CcSEcCtD
Zalcitabine—Anorexia—Dactinomycin—germ cell cancer	0.000372	0.00165	CcSEcCtD
Zalcitabine—Eye disorder—Etoposide—germ cell cancer	0.000371	0.00165	CcSEcCtD
Zalcitabine—Flushing—Etoposide—germ cell cancer	0.000369	0.00164	CcSEcCtD
Zalcitabine—Discomfort—Ifosfamide—germ cell cancer	0.000369	0.00163	CcSEcCtD
Zalcitabine—CYP2C9—endocrine gland—germ cell cancer	0.000367	0.00552	CbGeAlD
Zalcitabine—Hypersensitivity—Vinblastine—germ cell cancer	0.000365	0.00162	CcSEcCtD
Zalcitabine—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.000365	0.00162	CcSEcCtD
Zalcitabine—Decreased appetite—Bleomycin—germ cell cancer	0.000364	0.00161	CcSEcCtD
Zalcitabine—Muscle spasms—Cisplatin—germ cell cancer	0.000363	0.00161	CcSEcCtD
Zalcitabine—Confusional state—Ifosfamide—germ cell cancer	0.000361	0.0016	CcSEcCtD
Zalcitabine—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.000358	0.0877	CbGpPWpGaD
Zalcitabine—Pain—Bleomycin—germ cell cancer	0.000358	0.00159	CcSEcCtD
Zalcitabine—Oedema—Ifosfamide—germ cell cancer	0.000358	0.00159	CcSEcCtD
Zalcitabine—Chills—Etoposide—germ cell cancer	0.000357	0.00158	CcSEcCtD
Zalcitabine—Vision blurred—Cisplatin—germ cell cancer	0.000356	0.00158	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000356	0.00158	CcSEcCtD
Zalcitabine—Asthenia—Vinblastine—germ cell cancer	0.000355	0.00158	CcSEcCtD
Zalcitabine—Infection—Ifosfamide—germ cell cancer	0.000355	0.00158	CcSEcCtD
Zalcitabine—Tremor—Cisplatin—germ cell cancer	0.000354	0.00157	CcSEcCtD
Zalcitabine—Alopecia—Etoposide—germ cell cancer	0.000351	0.00156	CcSEcCtD
Zalcitabine—Ill-defined disorder—Cisplatin—germ cell cancer	0.00035	0.00155	CcSEcCtD
Zalcitabine—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00035	0.00155	CcSEcCtD
Zalcitabine—Anaemia—Cisplatin—germ cell cancer	0.000349	0.00155	CcSEcCtD
Zalcitabine—Skin disorder—Ifosfamide—germ cell cancer	0.000347	0.00154	CcSEcCtD
Zalcitabine—CYP3A43—Metapathway biotransformation—NAT9—germ cell cancer	0.000347	0.0849	CbGpPWpGaD
Zalcitabine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000346	0.00153	CcSEcCtD
Zalcitabine—Feeling abnormal—Bleomycin—germ cell cancer	0.000345	0.00153	CcSEcCtD
Zalcitabine—Osteoarthritis—Methotrexate—germ cell cancer	0.000344	0.00153	CcSEcCtD
Zalcitabine—Anorexia—Ifosfamide—germ cell cancer	0.000341	0.00151	CcSEcCtD
Zalcitabine—Malaise—Cisplatin—germ cell cancer	0.000341	0.00151	CcSEcCtD
Zalcitabine—Decreased appetite—Dactinomycin—germ cell cancer	0.000339	0.0015	CcSEcCtD
Zalcitabine—Diarrhoea—Vinblastine—germ cell cancer	0.000339	0.0015	CcSEcCtD
Zalcitabine—Dysgeusia—Etoposide—germ cell cancer	0.000339	0.0015	CcSEcCtD
Zalcitabine—Leukopenia—Cisplatin—germ cell cancer	0.000338	0.0015	CcSEcCtD
Zalcitabine—Fatigue—Dactinomycin—germ cell cancer	0.000336	0.00149	CcSEcCtD
Zalcitabine—Back pain—Etoposide—germ cell cancer	0.000335	0.00148	CcSEcCtD
Zalcitabine—Pain—Dactinomycin—germ cell cancer	0.000334	0.00148	CcSEcCtD
Zalcitabine—Muscle spasms—Etoposide—germ cell cancer	0.000333	0.00148	CcSEcCtD
Zalcitabine—Urticaria—Bleomycin—germ cell cancer	0.000332	0.00147	CcSEcCtD
Zalcitabine—Body temperature increased—Bleomycin—germ cell cancer	0.000331	0.00147	CcSEcCtD
Zalcitabine—Dizziness—Vinblastine—germ cell cancer	0.000328	0.00145	CcSEcCtD
Zalcitabine—Convulsion—Cisplatin—germ cell cancer	0.000327	0.00145	CcSEcCtD
Zalcitabine—Mood swings—Methotrexate—germ cell cancer	0.000326	0.00145	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000326	0.00145	CcSEcCtD
Zalcitabine—Ataxia—Methotrexate—germ cell cancer	0.000324	0.00144	CcSEcCtD
Zalcitabine—Myalgia—Cisplatin—germ cell cancer	0.000322	0.00143	CcSEcCtD
Zalcitabine—Feeling abnormal—Dactinomycin—germ cell cancer	0.000322	0.00143	CcSEcCtD
Zalcitabine—Ill-defined disorder—Etoposide—germ cell cancer	0.000321	0.00142	CcSEcCtD
Zalcitabine—Anxiety—Cisplatin—germ cell cancer	0.00032	0.00142	CcSEcCtD
Zalcitabine—Anaemia—Etoposide—germ cell cancer	0.00032	0.00142	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000319	0.00142	CcSEcCtD
Zalcitabine—Dyspnoea—Ifosfamide—germ cell cancer	0.000319	0.00141	CcSEcCtD
Zalcitabine—Somnolence—Ifosfamide—germ cell cancer	0.000318	0.00141	CcSEcCtD
Zalcitabine—Discomfort—Cisplatin—germ cell cancer	0.000318	0.00141	CcSEcCtD
Zalcitabine—Vomiting—Vinblastine—germ cell cancer	0.000315	0.0014	CcSEcCtD
Zalcitabine—Malaise—Etoposide—germ cell cancer	0.000312	0.00138	CcSEcCtD
Zalcitabine—Vertigo—Etoposide—germ cell cancer	0.000311	0.00138	CcSEcCtD
Zalcitabine—Decreased appetite—Ifosfamide—germ cell cancer	0.000311	0.00138	CcSEcCtD
Zalcitabine—Headache—Vinblastine—germ cell cancer	0.00031	0.00138	CcSEcCtD
Zalcitabine—Leukopenia—Etoposide—germ cell cancer	0.00031	0.00137	CcSEcCtD
Zalcitabine—Abdominal pain—Dactinomycin—germ cell cancer	0.000308	0.00137	CcSEcCtD
Zalcitabine—Body temperature increased—Dactinomycin—germ cell cancer	0.000308	0.00137	CcSEcCtD
Zalcitabine—Fatigue—Ifosfamide—germ cell cancer	0.000308	0.00137	CcSEcCtD
Zalcitabine—Oedema—Cisplatin—germ cell cancer	0.000308	0.00137	CcSEcCtD
Zalcitabine—Hypersensitivity—Bleomycin—germ cell cancer	0.000308	0.00137	CcSEcCtD
Zalcitabine—Infection—Cisplatin—germ cell cancer	0.000306	0.00136	CcSEcCtD
Zalcitabine—Pain—Ifosfamide—germ cell cancer	0.000306	0.00136	CcSEcCtD
Zalcitabine—Loss of consciousness—Etoposide—germ cell cancer	0.000304	0.00135	CcSEcCtD
Zalcitabine—Cough—Etoposide—germ cell cancer	0.000302	0.00134	CcSEcCtD
Zalcitabine—Thrombocytopenia—Cisplatin—germ cell cancer	0.000302	0.00134	CcSEcCtD
Zalcitabine—Tachycardia—Cisplatin—germ cell cancer	0.000301	0.00133	CcSEcCtD
Zalcitabine—Asthenia—Bleomycin—germ cell cancer	0.0003	0.00133	CcSEcCtD
Zalcitabine—Convulsion—Etoposide—germ cell cancer	0.0003	0.00133	CcSEcCtD
Zalcitabine—Skin disorder—Cisplatin—germ cell cancer	0.000299	0.00133	CcSEcCtD
Zalcitabine—Hypertension—Etoposide—germ cell cancer	0.000299	0.00133	CcSEcCtD
Zalcitabine—Hyperhidrosis—Cisplatin—germ cell cancer	0.000298	0.00132	CcSEcCtD
Zalcitabine—CYP2D6—female gonad—germ cell cancer	0.000296	0.00445	CbGeAlD
Zalcitabine—Pruritus—Bleomycin—germ cell cancer	0.000296	0.00131	CcSEcCtD
Zalcitabine—Feeling abnormal—Ifosfamide—germ cell cancer	0.000295	0.00131	CcSEcCtD
Zalcitabine—Eosinophilia—Methotrexate—germ cell cancer	0.000295	0.00131	CcSEcCtD
Zalcitabine—Anorexia—Cisplatin—germ cell cancer	0.000294	0.0013	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000292	0.0013	CcSEcCtD
Zalcitabine—Pancreatitis—Methotrexate—germ cell cancer	0.000292	0.00129	CcSEcCtD
Zalcitabine—Discomfort—Etoposide—germ cell cancer	0.000291	0.00129	CcSEcCtD
Zalcitabine—Hypersensitivity—Dactinomycin—germ cell cancer	0.000287	0.00128	CcSEcCtD
Zalcitabine—Confusional state—Etoposide—germ cell cancer	0.000285	0.00126	CcSEcCtD
Zalcitabine—Urticaria—Ifosfamide—germ cell cancer	0.000284	0.00126	CcSEcCtD
Zalcitabine—Body temperature increased—Ifosfamide—germ cell cancer	0.000283	0.00125	CcSEcCtD
Zalcitabine—Abdominal pain—Ifosfamide—germ cell cancer	0.000283	0.00125	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000281	0.00125	CcSEcCtD
Zalcitabine—Infection—Etoposide—germ cell cancer	0.000281	0.00124	CcSEcCtD
Zalcitabine—CYP3A4—endocrine gland—germ cell cancer	0.00028	0.00421	CbGeAlD
Zalcitabine—Asthenia—Dactinomycin—germ cell cancer	0.00028	0.00124	CcSEcCtD
Zalcitabine—Neutropenia—Methotrexate—germ cell cancer	0.000278	0.00123	CcSEcCtD
Zalcitabine—Dysuria—Methotrexate—germ cell cancer	0.000278	0.00123	CcSEcCtD
Zalcitabine—Thrombocytopenia—Etoposide—germ cell cancer	0.000277	0.00123	CcSEcCtD
Zalcitabine—CYP2D6—endocrine gland—germ cell cancer	0.000276	0.00414	CbGeAlD
Zalcitabine—Tachycardia—Etoposide—germ cell cancer	0.000276	0.00122	CcSEcCtD
Zalcitabine—Dyspnoea—Cisplatin—germ cell cancer	0.000275	0.00122	CcSEcCtD
Zalcitabine—Skin disorder—Etoposide—germ cell cancer	0.000274	0.00122	CcSEcCtD
Zalcitabine—Hyperhidrosis—Etoposide—germ cell cancer	0.000273	0.00121	CcSEcCtD
Zalcitabine—CYP2D6—head—germ cell cancer	0.000272	0.00409	CbGeAlD
Zalcitabine—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000272	0.0012	CcSEcCtD
Zalcitabine—Anorexia—Etoposide—germ cell cancer	0.000269	0.00119	CcSEcCtD
Zalcitabine—Decreased appetite—Cisplatin—germ cell cancer	0.000268	0.00119	CcSEcCtD
Zalcitabine—Diarrhoea—Dactinomycin—germ cell cancer	0.000267	0.00118	CcSEcCtD
Zalcitabine—Vomiting—Bleomycin—germ cell cancer	0.000266	0.00118	CcSEcCtD
Zalcitabine—Depression—Methotrexate—germ cell cancer	0.000264	0.00117	CcSEcCtD
Zalcitabine—Rash—Bleomycin—germ cell cancer	0.000264	0.00117	CcSEcCtD
Zalcitabine—Pain—Cisplatin—germ cell cancer	0.000264	0.00117	CcSEcCtD
Zalcitabine—Dermatitis—Bleomycin—germ cell cancer	0.000264	0.00117	CcSEcCtD
Zalcitabine—Hypersensitivity—Ifosfamide—germ cell cancer	0.000263	0.00117	CcSEcCtD
Zalcitabine—CYP2D6—testis—germ cell cancer	0.000263	0.00395	CbGeAlD
Zalcitabine—SLC29A2—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	0.000257	0.0628	CbGpPWpGaD
Zalcitabine—Asthenia—Ifosfamide—germ cell cancer	0.000257	0.00114	CcSEcCtD
Zalcitabine—Feeling abnormal—Cisplatin—germ cell cancer	0.000254	0.00113	CcSEcCtD
Zalcitabine—Pruritus—Ifosfamide—germ cell cancer	0.000253	0.00112	CcSEcCtD
Zalcitabine—Dyspnoea—Etoposide—germ cell cancer	0.000252	0.00112	CcSEcCtD
Zalcitabine—Somnolence—Etoposide—germ cell cancer	0.000251	0.00111	CcSEcCtD
Zalcitabine—Epistaxis—Methotrexate—germ cell cancer	0.00025	0.00111	CcSEcCtD
Zalcitabine—Vomiting—Dactinomycin—germ cell cancer	0.000248	0.0011	CcSEcCtD
Zalcitabine—Rash—Dactinomycin—germ cell cancer	0.000246	0.00109	CcSEcCtD
Zalcitabine—Decreased appetite—Etoposide—germ cell cancer	0.000245	0.00109	CcSEcCtD
Zalcitabine—Diarrhoea—Ifosfamide—germ cell cancer	0.000245	0.00109	CcSEcCtD
Zalcitabine—Body temperature increased—Cisplatin—germ cell cancer	0.000244	0.00108	CcSEcCtD
Zalcitabine—Fatigue—Etoposide—germ cell cancer	0.000243	0.00108	CcSEcCtD
Zalcitabine—CYP2D6—cerebellum—germ cell cancer	0.000243	0.00365	CbGeAlD
Zalcitabine—Pain—Etoposide—germ cell cancer	0.000242	0.00107	CcSEcCtD
Zalcitabine—Hepatitis—Methotrexate—germ cell cancer	0.000238	0.00106	CcSEcCtD
Zalcitabine—Dizziness—Ifosfamide—germ cell cancer	0.000236	0.00105	CcSEcCtD
Zalcitabine—Pharyngitis—Methotrexate—germ cell cancer	0.000236	0.00105	CcSEcCtD
Zalcitabine—Feeling abnormal—Etoposide—germ cell cancer	0.000233	0.00103	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Etoposide—germ cell cancer	0.000231	0.00102	CcSEcCtD
Zalcitabine—Visual impairment—Methotrexate—germ cell cancer	0.000229	0.00102	CcSEcCtD
Zalcitabine—Vomiting—Ifosfamide—germ cell cancer	0.000227	0.00101	CcSEcCtD
Zalcitabine—Hypersensitivity—Cisplatin—germ cell cancer	0.000227	0.00101	CcSEcCtD
Zalcitabine—Rash—Ifosfamide—germ cell cancer	0.000225	0.001	CcSEcCtD
Zalcitabine—Dermatitis—Ifosfamide—germ cell cancer	0.000225	0.000999	CcSEcCtD
Zalcitabine—Urticaria—Etoposide—germ cell cancer	0.000224	0.000995	CcSEcCtD
Zalcitabine—Abdominal pain—Etoposide—germ cell cancer	0.000223	0.00099	CcSEcCtD
Zalcitabine—Body temperature increased—Etoposide—germ cell cancer	0.000223	0.00099	CcSEcCtD
Zalcitabine—Eye disorder—Methotrexate—germ cell cancer	0.000223	0.000987	CcSEcCtD
Zalcitabine—Tinnitus—Methotrexate—germ cell cancer	0.000222	0.000985	CcSEcCtD
Zalcitabine—Asthenia—Cisplatin—germ cell cancer	0.000221	0.000981	CcSEcCtD
Zalcitabine—Chills—Methotrexate—germ cell cancer	0.000214	0.000948	CcSEcCtD
Zalcitabine—Diarrhoea—Cisplatin—germ cell cancer	0.000211	0.000936	CcSEcCtD
Zalcitabine—Alopecia—Methotrexate—germ cell cancer	0.00021	0.000933	CcSEcCtD
Zalcitabine—Hypersensitivity—Etoposide—germ cell cancer	0.000208	0.000923	CcSEcCtD
Zalcitabine—Dysgeusia—Methotrexate—germ cell cancer	0.000203	0.0009	CcSEcCtD
Zalcitabine—Asthenia—Etoposide—germ cell cancer	0.000203	0.000899	CcSEcCtD
Zalcitabine—Back pain—Methotrexate—germ cell cancer	0.0002	0.000889	CcSEcCtD
Zalcitabine—Pruritus—Etoposide—germ cell cancer	0.0002	0.000886	CcSEcCtD
Zalcitabine—CYP2D6—brain—germ cell cancer	0.000197	0.00296	CbGeAlD
Zalcitabine—Vomiting—Cisplatin—germ cell cancer	0.000196	0.000869	CcSEcCtD
Zalcitabine—Vision blurred—Methotrexate—germ cell cancer	0.000195	0.000867	CcSEcCtD
Zalcitabine—Rash—Cisplatin—germ cell cancer	0.000194	0.000862	CcSEcCtD
Zalcitabine—Dermatitis—Cisplatin—germ cell cancer	0.000194	0.000861	CcSEcCtD
Zalcitabine—Diarrhoea—Etoposide—germ cell cancer	0.000193	0.000857	CcSEcCtD
Zalcitabine—Ill-defined disorder—Methotrexate—germ cell cancer	0.000192	0.000853	CcSEcCtD
Zalcitabine—Anaemia—Methotrexate—germ cell cancer	0.000192	0.00085	CcSEcCtD
Zalcitabine—Malaise—Methotrexate—germ cell cancer	0.000187	0.000829	CcSEcCtD
Zalcitabine—Dizziness—Etoposide—germ cell cancer	0.000187	0.000828	CcSEcCtD
Zalcitabine—Vertigo—Methotrexate—germ cell cancer	0.000186	0.000826	CcSEcCtD
Zalcitabine—Leukopenia—Methotrexate—germ cell cancer	0.000186	0.000823	CcSEcCtD
Zalcitabine—Cough—Methotrexate—germ cell cancer	0.000181	0.000802	CcSEcCtD
Zalcitabine—Convulsion—Methotrexate—germ cell cancer	0.00018	0.000797	CcSEcCtD
Zalcitabine—Vomiting—Etoposide—germ cell cancer	0.00018	0.000797	CcSEcCtD
Zalcitabine—Rash—Etoposide—germ cell cancer	0.000178	0.00079	CcSEcCtD
Zalcitabine—SLC29A1—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	0.000178	0.0435	CbGpPWpGaD
Zalcitabine—Dermatitis—Etoposide—germ cell cancer	0.000178	0.000789	CcSEcCtD
Zalcitabine—Headache—Etoposide—germ cell cancer	0.000177	0.000785	CcSEcCtD
Zalcitabine—Myalgia—Methotrexate—germ cell cancer	0.000176	0.000783	CcSEcCtD
Zalcitabine—Arthralgia—Methotrexate—germ cell cancer	0.000176	0.000783	CcSEcCtD
Zalcitabine—Discomfort—Methotrexate—germ cell cancer	0.000174	0.000773	CcSEcCtD
Zalcitabine—Confusional state—Methotrexate—germ cell cancer	0.000171	0.000757	CcSEcCtD
Zalcitabine—Infection—Methotrexate—germ cell cancer	0.000168	0.000745	CcSEcCtD
Zalcitabine—Thrombocytopenia—Methotrexate—germ cell cancer	0.000166	0.000735	CcSEcCtD
Zalcitabine—Skin disorder—Methotrexate—germ cell cancer	0.000164	0.000729	CcSEcCtD
Zalcitabine—Hyperhidrosis—Methotrexate—germ cell cancer	0.000164	0.000725	CcSEcCtD
Zalcitabine—Anorexia—Methotrexate—germ cell cancer	0.000161	0.000715	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000154	0.000684	CcSEcCtD
Zalcitabine—Insomnia—Methotrexate—germ cell cancer	0.000153	0.000679	CcSEcCtD
Zalcitabine—Dyspnoea—Methotrexate—germ cell cancer	0.000151	0.000669	CcSEcCtD
Zalcitabine—Somnolence—Methotrexate—germ cell cancer	0.00015	0.000667	CcSEcCtD
Zalcitabine—Dyspepsia—Methotrexate—germ cell cancer	0.000149	0.000661	CcSEcCtD
Zalcitabine—Decreased appetite—Methotrexate—germ cell cancer	0.000147	0.000652	CcSEcCtD
Zalcitabine—Fatigue—Methotrexate—germ cell cancer	0.000146	0.000647	CcSEcCtD
Zalcitabine—Pain—Methotrexate—germ cell cancer	0.000145	0.000642	CcSEcCtD
Zalcitabine—CYP3A7—Metapathway biotransformation—NAT9—germ cell cancer	0.00014	0.0342	CbGpPWpGaD
Zalcitabine—Feeling abnormal—Methotrexate—germ cell cancer	0.000139	0.000618	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000138	0.000614	CcSEcCtD
Zalcitabine—Urticaria—Methotrexate—germ cell cancer	0.000134	0.000596	CcSEcCtD
Zalcitabine—Abdominal pain—Methotrexate—germ cell cancer	0.000134	0.000593	CcSEcCtD
Zalcitabine—Body temperature increased—Methotrexate—germ cell cancer	0.000134	0.000593	CcSEcCtD
Zalcitabine—Hypersensitivity—Methotrexate—germ cell cancer	0.000125	0.000553	CcSEcCtD
Zalcitabine—Asthenia—Methotrexate—germ cell cancer	0.000121	0.000538	CcSEcCtD
Zalcitabine—Pruritus—Methotrexate—germ cell cancer	0.00012	0.000531	CcSEcCtD
Zalcitabine—SLC29A2—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.00012	0.0292	CbGpPWpGaD
Zalcitabine—SLC29A2—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000118	0.0288	CbGpPWpGaD
Zalcitabine—Diarrhoea—Methotrexate—germ cell cancer	0.000116	0.000513	CcSEcCtD
Zalcitabine—Dizziness—Methotrexate—germ cell cancer	0.000112	0.000496	CcSEcCtD
Zalcitabine—Vomiting—Methotrexate—germ cell cancer	0.000108	0.000477	CcSEcCtD
Zalcitabine—Rash—Methotrexate—germ cell cancer	0.000107	0.000473	CcSEcCtD
Zalcitabine—Dermatitis—Methotrexate—germ cell cancer	0.000107	0.000473	CcSEcCtD
Zalcitabine—Headache—Methotrexate—germ cell cancer	0.000106	0.00047	CcSEcCtD
Zalcitabine—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000104	0.0254	CbGpPWpGaD
Zalcitabine—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000102	0.025	CbGpPWpGaD
Zalcitabine—CYP3A5—Metapathway biotransformation—NAT9—germ cell cancer	0.000101	0.0247	CbGpPWpGaD
Zalcitabine—SLC29A2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	9.28e-05	0.0227	CbGpPWpGaD
Zalcitabine—DCK—Retinoblastoma (RB) in Cancer—H2AFZ—germ cell cancer	8.58e-05	0.021	CbGpPWpGaD
Zalcitabine—SLC29A1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	8.28e-05	0.0203	CbGpPWpGaD
Zalcitabine—SLC29A1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	8.16e-05	0.02	CbGpPWpGaD
Zalcitabine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	7.29e-05	0.0178	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—NAT9—germ cell cancer	7.18e-05	0.0176	CbGpPWpGaD
Zalcitabine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	7.18e-05	0.0176	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—NAT9—germ cell cancer	7.12e-05	0.0174	CbGpPWpGaD
Zalcitabine—SLC29A1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	6.43e-05	0.0157	CbGpPWpGaD
Zalcitabine—SLC29A1—Fluoropyrimidine Activity—TP53—germ cell cancer	6.28e-05	0.0154	CbGpPWpGaD
Zalcitabine—SLC29A2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	6.07e-05	0.0149	CbGpPWpGaD
Zalcitabine—SLC29A2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	5.98e-05	0.0146	CbGpPWpGaD
Zalcitabine—SLC29A2—SLC-mediated transmembrane transport—AVP—germ cell cancer	5.51e-05	0.0135	CbGpPWpGaD
Zalcitabine—SLC22A7—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	4.72e-05	0.0115	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	4.69e-05	0.0115	CbGpPWpGaD
Zalcitabine—SLC22A7—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	4.65e-05	0.0114	CbGpPWpGaD
Zalcitabine—SLC29A1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	4.21e-05	0.0103	CbGpPWpGaD
Zalcitabine—SLC29A1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.15e-05	0.0101	CbGpPWpGaD
Zalcitabine—SLC29A1—SLC-mediated transmembrane transport—AVP—germ cell cancer	3.82e-05	0.00935	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	3.67e-05	0.00897	CbGpPWpGaD
Zalcitabine—SLC22A7—Fluoropyrimidine Activity—TP53—germ cell cancer	3.58e-05	0.00876	CbGpPWpGaD
Zalcitabine—SLC22A6—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	3.31e-05	0.0081	CbGpPWpGaD
Zalcitabine—SLC22A6—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	3.26e-05	0.00798	CbGpPWpGaD
Zalcitabine—DCK—Retinoblastoma (RB) in Cancer—MYC—germ cell cancer	2.96e-05	0.00725	CbGpPWpGaD
Zalcitabine—SLC29A2—Transmembrane transport of small molecules—AVP—germ cell cancer	2.8e-05	0.00685	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	2.57e-05	0.00629	CbGpPWpGaD
Zalcitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—germ cell cancer	2.43e-05	0.00596	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	2.4e-05	0.00587	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	2.36e-05	0.00578	CbGpPWpGaD
Zalcitabine—SLC22A7—SLC-mediated transmembrane transport—AVP—germ cell cancer	2.18e-05	0.00533	CbGpPWpGaD
Zalcitabine—SLC29A1—Transmembrane transport of small molecules—AVP—germ cell cancer	1.94e-05	0.00475	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	1.68e-05	0.00412	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—SLC2A3—germ cell cancer	1.66e-05	0.00406	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	1.66e-05	0.00406	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—SLC22A3—germ cell cancer	1.63e-05	0.004	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—SLC2A3—germ cell cancer	1.63e-05	0.004	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—SLC22A3—germ cell cancer	1.61e-05	0.00394	CbGpPWpGaD
Zalcitabine—SLC22A6—SLC-mediated transmembrane transport—AVP—germ cell cancer	1.53e-05	0.00374	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CRABP1—germ cell cancer	1.33e-05	0.00326	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CRABP1—germ cell cancer	1.31e-05	0.00321	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—AVP—germ cell cancer	1.11e-05	0.00271	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—AVP—germ cell cancer	7.76e-06	0.0019	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—SLC2A3—germ cell cancer	6.58e-06	0.00161	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—SLC22A3—germ cell cancer	6.48e-06	0.00159	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	6.05e-06	0.00148	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CRABP1—germ cell cancer	5.28e-06	0.00129	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—SLC2A3—germ cell cancer	4.76e-06	0.00116	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—SLC22A3—germ cell cancer	4.68e-06	0.00115	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CRABP1—germ cell cancer	3.82e-06	0.000935	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SLC2A3—germ cell cancer	3.38e-06	0.000828	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SLC2A3—germ cell cancer	3.35e-06	0.00082	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SLC22A3—germ cell cancer	3.33e-06	0.000815	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SLC22A3—germ cell cancer	3.3e-06	0.000808	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CRABP1—germ cell cancer	2.72e-06	0.000665	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CRABP1—germ cell cancer	2.69e-06	0.000659	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SLC2A3—germ cell cancer	2.21e-06	0.000541	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SLC22A3—germ cell cancer	2.18e-06	0.000533	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CRABP1—germ cell cancer	1.78e-06	0.000434	CbGpPWpGaD
